Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gargulák

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|May 5, 2017
[Zinc-modified Nanotransporter for Target Drug Therapy of Breast Cancer]S Skaličková, M Gargulák, M Löffelmann, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|May 5, 2017
[Fullerene Doxorubicin Nanotransporter for Target Interaction with mutated gene BRCA2]S Skaličková, M Löfelmann, M Gargulák, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|June 21, 2019
Nanoparticle-Modified Apoferritin Nanotransfer for Targeted Cytostatic TransportM Čížek, M Gargulák, K Sehnal, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|May 5, 2017
[Zinc-modified Nanotransporter for Target Drug Therapy of Breast Cancer]S Skaličková, M Gargulák, M Löffelmann, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|May 5, 2017
[Fullerene Doxorubicin Nanotransporter for Target Interaction with mutated gene BRCA2]S Skaličková, M Löfelmann, M Gargulák, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|June 21, 2019
Nanoparticle-Modified Apoferritin Nanotransfer for Targeted Cytostatic TransportM Čížek, M Gargulák, K Sehnal, et al.
Pageof 1